LMT
39
10
NOV
47
2
XEL
51
3
RRC
58
6
PFG
30
3
GOOGL
64
2
ES
26
14
MCHP
36
3
ADI
57
2
MA
62
2
EXPE
86
3
NUE
39
2
DIS
68
-2
PHM
46
2
LUV
48
3
FDX
33
-11
HAL
30
-10
STI
21
9
K
48
3
CI
38
3
LMT
39
10
NOV
47
2
XEL
51
3
RRC
58
6
PFG
30
3
GOOGL
64
2
ES
26
14
MCHP
36
3
ADI
57
2
MA
62
2
EXPE
86
3
NUE
39
2
DIS
68
-2
PHM
46
2
LUV
48
3
FDX
33
-11
HAL
30
-10
STI
21
9
K
48
3
CI
38
3
Financhill
Back

Thomson Reuters Vs. Kymera Therapeutics Industry Stock Comparison

Sell
40

TRI.TO
Thomson Reuters

Last Price:
$233.92
Seasonality Move:
3.73%
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.93
Seasonality Move:
2.79%
Sell
40
Thomson Reuters (TRI.TO) is a Sell

Is Thomson Reuters a Buy, Sell or Hold?

  • The current Thomson Reuters [TRI.TO] share price is $234.53. The Score for TRI.TO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • TRI.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.79. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRI.TO Stock Price Chart

What is Thomson Reuters's stock price today?

  • The Thomson Reuters share price today is $234.53
    The current trend is moderately bearish and TRI.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRI.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.34 Buy
Relative Strength Index (14 RSI): 50.11 Buy
Chaikin Money Flow: 100210 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (227.05 - 239.09) Buy
Bollinger Bands (100): (224.82 - 235.18) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 40.6 Sell
Chaikin Money Flow: 196490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.49 - 46.41) Sell
Bollinger Bands (100): (42.83 - 48.77) Sell

TRI.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 236.91 Sell
20-day SMA: 235.09 Sell
50-day SMA: 232.43 Buy
200-day SMA: 226.25 Buy
8-day EMA: 235.88 Sell
20-day EMA: 235.16 Sell
50-day EMA: 232.93 Buy
200-day EMA: 223.48 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.15 Sell
20-day SMA: 44.05 Sell
50-day SMA: 45.84 Sell
200-day SMA: 41.3 Sell
8-day EMA: 41.35 Sell
20-day EMA: 43.14 Sell
50-day EMA: 44.71 Sell
200-day EMA: 41.09 Sell

Thomson Reuters Earnings Growth & TRI.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.44 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Thomson Reuters Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):